Peptide questions · PT-141

PT-141 side effects: what studies and users report

Reviewed Evidence: EstablishedPublished by PepVault

The side effects most commonly reported for PT-141 are nausea (most common), flushing and blood pressure elevation, among 5 the library lists; the library’s evidence on it includes controlled trials in people.

The library holds no separate safety note for PT-141.

What is commonly reported with PT-141

  • Nausea (most common)
  • Flushing
  • Blood pressure elevation
  • Spontaneous erections
  • Hyperpigmentation with frequent use

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other sexual health compounds the library lists it for
EffectAlso listed for (of 7)
Nausea (most common)2: Melanotan II, Melanotan I
FlushingNone: listed for PT-141 alone
Blood pressure elevationNone: listed for PT-141 alone
Spontaneous erections1: Melanotan II
Hyperpigmentation with frequent useNone: listed for PT-141 alone
A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Track PT-141 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Which PT-141 side effects the sexual health group shares

Across the 8 sexual health compounds in the library, the effects listed most often are fatigue (3 of 8), headache (3 of 8), nausea (most common) (3 of 8) and facial flushing (2 of 8). PT-141 shares 2 of its 5 listed effects with at least one other sexual health compound; flushing, blood pressure elevation and hyperpigmentation with frequent use are listed for PT-141 alone.

Where the PT-141 reports come from

The library rates the evidence on PT-141 as established: clinical trials or FDA-approved use exist.

Of the library’s 7 research notes on PT-141, 5 rest on randomized trials, 1 on clinical data and 1 on community reports.

Our 6 study pages on PT-141: 1 systematic review (human), 4 randomized trials and 1 meta-analysis.

So PT-141 has controlled trials in people to set its listed effects against.

What our PT-141 study pages report on safety

PT-141: nausea in 40.0% vs 1.3% on placebo in phase 3 safety data

Systematic review, human, 2022: In the pooled phase 3 data, nausea was the most common side effect (40.0% on bremelanotide vs 1.3% on placebo, a dummy shot), followed by flushing (20.3% vs 1.3%), headache (11.3% vs 1.9%) and injection site reactions (5.4 vs 0.5). Nausea was the top reason people stopped the drug, and 70% of the bremelanotide group moved on to the open-label phase vs 87% of the placebo group.

PT-141: side-effect dropouts far higher than placebo in re-analysis

Meta-analysis, human, 2021: Women on bremelanotide had much higher odds of leaving the trial because of side effects (odds ratio 11.98, 95% CI 3.74-38.37, number needed to harm 6). This re-analysis of the main PT-141 trials in women with low sexual desire found modest benefits and much higher odds of quitting due to side effects than on placebo, and it concludes the drug is generally not useful.

PT-141: more responders than placebo at 1.75 mg on all 7 measures

Randomized trial, human, 2019: The team reported bremelanotide was safe and well tolerated in this trial.

PT-141 with alcohol was well tolerated in 24 healthy adults

Randomized trial, human, 2017: The 20 mg nasal doses were judged safe and mostly well tolerated, with or without alcohol, and women reached average peak blood alcohol levels above 80 mg/dL. Bremelanotide did not raise the rate of side effects, no one dropped out because of side effects, and physical exams, ECGs (heart tracings) and lab tests showed no clinically significant changes.

PT-141: +0.7 vs +0.2 satisfying sexual events a month at 12 weeks

Randomized trial, human, 2016: The side effects named were nausea, flushing and headache. In premenopausal women, the higher PT-141 doses added a small gain in satisfying sexual events over placebo, and nausea, flushing and headache were the side effects that came up.

Questions people ask

What are the side effects of PT-141?

The side effects most commonly reported for PT-141 are nausea (most common), flushing and blood pressure elevation, among 5 the library lists; the library’s evidence on it includes controlled trials in people.

Do PT-141’s side effects come from human studies?

The library rates the evidence on PT-141 as established, and the library’s evidence on it includes controlled trials in people.

Which PT-141 side effects are its own?

Among the sexual health compounds, the library lists flushing, blood pressure elevation and hyperpigmentation with frequent use for PT-141 alone.

More on PT-141

Track it in the app

PepVault for iPhone

Track PT-141 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo